Terms: = Breast cancer AND MSN, P26038, 4478, ENSG00000147065 AND Diagnosis
6 results:
1. A Review on Recent Technologies and Patents on Silica Nanoparticles for cancer Treatment and diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract] [Full Text] [Related]
2. A versatile nanoplatform for synergistic chemo-photothermal therapy and multimodal imaging against breast cancer.
Li T; Geng Y; Zhang H; Wang J; Feng Y; Chen Z; Xie X; Qin X; Li S; Wu C; Liu Y; Yang H
Expert Opin Drug Deliv; 2020 May; 17(5):725-733. PubMed ID: 32098527
[No Abstract] [Full Text] [Related]
3. Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective breast cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.
Dréau D; Moore LJ; Alvarez-Berrios MP; Tarannum M; Mukherjee P; Vivero-Escoto JL
J Biomed Nanotechnol; 2016 Dec; 12(12):2172-2184. PubMed ID: 28522938
[TBL] [Abstract] [Full Text] [Related]
4. Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent.
Milgroom A; Intrator M; Madhavan K; Mazzaro L; Shandas R; Liu B; Park D
Colloids Surf B Biointerfaces; 2014 Apr; 116():652-7. PubMed ID: 24269054
[TBL] [Abstract] [Full Text] [Related]
5. Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.
Xie M; Shi H; Ma K; Shen H; Li B; Shen S; Wang X; Jin Y
J Colloid Interface Sci; 2013 Apr; 395():306-14. PubMed ID: 23394807
[TBL] [Abstract] [Full Text] [Related]
6. breast carcinoma survival in Europe and the United States.
Sant M; Allemani C; Berrino F; Coleman MP; Aareleid T; Chaplain G; Coebergh JW; Colonna M; Crosignani P; Danzon A; Federico M; Gafà L; Grosclaude P; Hédelin G; Macè-Lesech J; Garcia CM; Møller H; Paci E; Raverdy N; Tretarre B; Williams EM;
Cancer; 2004 Feb; 100(4):715-22. PubMed ID: 14770426
[TBL] [Abstract] [Full Text] [Related]
